Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation.
Ontology highlight
ABSTRACT: Identifying the antigens that have the potential to trigger endogenous antitumor responses in an individual cancer patient is likely to enhance the efficacy of cancer immunotherapy, but current methodologies do not efficiently identify such antigens. This study describes what we believe to be a new method of comprehensively identifying candidate tissue antigens that spontaneously cause T cell responses in disease situations. We used the newly developed automated, two-dimensional chromatography system PF2D to fractionate the proteome of human tumor tissues and tested protein fractions for recognition by preexisting tumor-specific CD4+ Th cells and CTLs. Applying this method using mice transgenic for a TCR that recognizes an OVA peptide presented by MHC class I, we demonstrated efficient sep
SUBMITTER: Beckhove P
PROVIDER: S-EPMC2877924 | biostudies-literature | 2010 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA